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Abstract
Background: Androgen receptor (AR) controls male morphogenesis, gametogenesis and prostate growth as well as
development of prostate cancer. These findings support a role for AR in cell migration and invasiveness. However, the
molecular mechanism involved in AR-mediated cell migration still remains elusive.
Methodology/Principal Findings: Mouse embryo NIH3T3 fibroblasts and highly metastatic human fibrosarcoma HT1080
cells harbor low levels of transcriptionally incompetent AR. We now report that, through extra nuclear action, AR triggers
migration of both cell types upon stimulation with physiological concentrations of the androgen R1881. We analyzed the
initial events leading to androgen-induced cell migration and observed that challenging NIH3T3 cells with 10 nM R1881
rapidly induces interaction of AR with filamin A (FlnA) at cytoskeleton. AR/FlnA complex recruits integrin beta 1, thus
activating its dependent cascade. Silencing of AR, FlnA and integrin beta 1 shows that this ternary complex controls focal
adhesion kinase (FAK), paxillin and Rac, thereby driving cell migration. FAK-null fibroblasts migrate poorly and Rac inhibition
by EHT impairs motility of androgen-treated NIH3T3 cells. Interestingly, FAK and Rac activation by androgens are
independent of each other. Findings in human fibrosarcoma HT1080 cells strengthen the role of Rac in androgen signaling.
The Rac inhibitor significantly impairs androgen-induced migration in these cells. A mutant AR, deleted of the sequence
interacting with FlnA, fails to mediate FAK activation and paxillin tyrosine phosphorylation in androgen-stimulated cells,
further reinforcing the role of AR/FlnA interaction in androgen-mediated motility.
Conclusions/Significance: The present report, for the first time, indicates that the extra nuclear AR/FlnA/integrin beta 1
complex is the key by which androgen activates signaling leading to cell migration. Assembly of this ternary complex may
control organ development and prostate cancer metastasis.
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Introduction
AR controls morphogenesis, gametogenesis and prostate growth at
puberty. It also represents a hallmark of prostate cancer in adults.
These processes occur through a reciprocal interplay between
epithelial and mesenchymal cells. Urogenital sinus mesenchyme
induces, for instance, development and differentiation of epithelial
cells that in turn control differentiation and localization of
mesenchymal progenitors. Again, proper development of the genital
tubercle and the embryonic anlage of external genitalia in the male
phenotype also require coordinated outgrowth of the mesodermally-
derived mesenchyme and extension of the endodermal urethra within
an ectodermal epithelial capsule. The re-awakening of mesenchymal
interactions are involved in benign prostate hyperplasia and prostate
cancer in adults [1]. Taken together, this evidence raises the question
as to whether androgens and AR directly control mesenchymal cells
as well as their migratory phenotype.
Fibroblasts and keratinocytes express AR during wound healing
[2], and stromal AR may play opposite roles in different stages of
prostate cancer, either blocking or promoting prostate cancer
metastasis [3]. We previously reported that NIH3T3 fibroblasts
and mouse embryo fibroblasts (MEFs) harbor classical AR [4]. In
NIH3T3 cells, this receptor is localized outside the nucleus and
does not activate gene transcription. It does, nevertheless, activate
various signaling effectors and triggers different phenotypes
depending on hormone concentration. At suboptimal R1881
concentration (1 pM), AR induces S-phase entry through
recruitment and activation of Src as well as phosphatidylinositol-
3-kinase (PI3-K; proliferative phenotype). At a more physiological
androgen concentration (10 nM), AR only slightly increases S-
phase entry, whereas it triggers Rac 1 activation and cytoskeleton
changes (migratory phenotype) in the absence of association with
Src and PI3-K [4]. This suggests that AR associates with other
effectors to regulate cell migration.
Physiological androgen concentration (10 nM) also induces G0/
G1 arrest and cytoskeleton changes in human fibrosarcoma
HT1080 cells engineered to stably express high levels of AR [5].
AR knockout retards neutrophil maturation and reduces their
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migration and invasiveness. However, they do not address the
molecular mechanism underlying these processes.
The filamin (Fln) family consists of three homologous proteins,
A, B and C. Mouse models of Fln deficiency have underlined the
regulatory role of these proteins in cell migration [7]. Indeed,
mutations in Fln genes (A and B) cause a wide range of brain,
bone, skeleton and heart developmental malformations, likely due
to severe defects in embryonic cell migration as well as to the
failure of Fln to interact with other proteins [8]. FlnA and its
proteolytic fragments directly interact with AR, thereby modulat-
ing nuclear translocation and transcriptional action of AR as well
as androgen dependence of prostate cancer LNCaP cells [9,10,11].
Further, cytoplasmic localization of FlnA has been correlated with
metastatic and hormone-refractory phenotypes in human prostate
cancer, suggesting that intracellular localization of FlnA orches-
trates invasiveness and even hormone responsiveness of prostate
cancers [12]. FlnA also recruits and activates the downstream
effector of GTPases, PAK-1 [13]. Rapid activation of this kinase
by estradiol has been reported in breast cancer cells and has been
correlated to modifications in shape and polarity of these cells
[14]. Remarkably, the non-genomic activation of PAK-1 by
estradiol controls hormone negative feedback actions in the
reproductive axis in vivo [15]. In sum, FlnA intersects steroid
action at different levels and in different cellular compartments by
directly anchoring steroid receptors (eg AR) or signaling effectors
(GTPases and their upstream or downstream molecules) that
mediate rapid steroid effects.
Here, we report that 10 nM R1881 significantly enhances
association and co-localization of AR with FlnA at cytoskeleton of
NIH3T3 fibroblasts. This complex also recruits integrin beta 1.
The androgen-driven assembly of AR/FlnA/integrin beta 1
complex induces activation of Rac 1 and FAK, which both
coordinate migration. Results with human fibrosarcoma HT1080
cells strengthen the significance of these findings. Like NIH3T3
cells, HT1080 cells harbor low levels of AR and undergo cell
migration upon androgen stimulation. The present findings
provide new clues explaining the regulatory role of FlnA in
androgen-regulated cell motility in mesenchymal cells and reveal a
novel and unexpected role for AR/FlnA interaction in the extra
nuclear compartment of cells. This complex acts as a linker
between androgen signaling and actin cytoskeleton, thereby
driving cell migration. It may affect human organ development
as well as cancer progression and could thus offer a new target to
gain a more tailored therapy of androgen-dependent human
cancers.
Results
Androgen induces migration of NIH3T3 fibroblasts
NIH3T3 cells harbor a very low amount of AR as compared to
that expressed in prostate cancer-derived LNCaP cells (upper
panel in Fig. 1A) and [4]. Upon 10 nM R1881 stimulation of
NIH3T3 cells, this receptor rapidly activates Rac 1 thereby
promoting cytoskeleton changes [4]. To determine whether these
changes trigger cell migration, quiescent NIH3T3 cells were
wounded and allowed to migrate in the absence or presence of the
compounds indicated in Fig. 1A (lower panels). Contrast-phase
images show that wound area was significantly reduced in cells
treated with 10 nM R1881. In contrast, only few cells migrated
upon treatment with a very low R1881 concentration (1 pM),
which induces a proliferative phenotype [4]. Addition of the anti-
androgen Casodex consistently inhibited the 10 nM androgen-
induced effect, indicating that classical AR is involved in this
response. Control images captured at 0-time or from untreated
cells are shown for comparison. Neither estradiol nor progestin
R5020 affected migration of NIH3T3 cells, which do not express
estradiol receptor alpha (ER alpha) or progesterone receptor (PR;
Fig. S1) and [4]. These results further confirm that AR mediates
androgen stimulation of NIH3T3 cell migration.
Consistent with findings in Fig. 1A, panel B shows that
stimulation of quiescent NIH3T3 cells with 10 nM R1881
increases by 3-fold the number of cells migrated through
collagen-coated (left graph) or uncoated (right graph) Transwell
filters. Similar data were obtained using 10 nM androgen
dihydrotestosterone (DHT, not shown). A negligible effect was
observed in cells challenged with low R1881 concentration (1 pM).
Here again, the 10 nM R1881-induced effect was significantly
reduced by addition of the androgen antagonist Casodex, thus
supporting the view that classical AR mediates the observed
effects. This issue was conclusively addressed by the experiment in
panel C showing that AR knockdown markedly inhibits the
number of migrated cells upon androgen stimulation. The
Western blot in Fig. 1D shows that AR expression is almost
completely abolished by siRNA (upper panel) in the presence of
equal amounts of loaded tubulin (lower panel).
Finally, NIH3T3 cells were followed in video time-lapse
microscopy for 24 h and migration was quantitatively evaluated
by recording the paths followed by each cell. Fig. 1E (left graph)
shows that treatment of NIH3T3 fibroblasts with 10 nM R1881
increases the average speed from about 5 to 8 mm/40 min, as
measured by averaging all cell displacements. The effect on
motility speed is consistently present during the whole observation
time, as demonstrated by averaging cell displacements at each
time step (not shown). Path linearity was also evaluated as the ratio
between net displacement and path length for each observed cell.
Right graph in Fig. 1E shows that R1881 fails to produce any
significant effects. It also indicates that the various cell populations
show similar distributions. Thus, 10 nM R1881 affects migration
speed without altering migration type.
In conclusion, data in Fig. 1 show that 10 nM R1881 enhances
migration of NIH3T3 fibroblasts through classical AR.
Androgen modifies cytoskeleton and increases focal
adhesions as well as tyrosine phosphorylation of FAK and
paxillin in NIH3T3 fibroblasts
Changes in the cytoskeleton architecture and tyrosine phos-
phorylation of proteins at focal contact sites are hallmarks of
migrating cells. In a preliminary experiment, we analyzed actin
remodeling upon androgen treatment of NIH3T3 cells in a time
course experiment (Fig. S2). Ten nM R1881 treatment induces
membrane ruffling and protrusions in NIH3T3 fibroblasts within
20 minutes. These changes are dynamically shut off within 1 h
(Fig. S2) and [10]. A more prolonged stimulation with 10 nM
R1881 slightly affects the actin organization (Fig. S2). These latter
findings do not exclude, however, that very rapid and periodic
waves of actin remodeling occur to accomplish cell migration
[16,17].
We then investigated by immunofluorescence (IF) analysis the
effect of androgens on actin remodeling and P-Tyr distribution in
NIH3T3 cells. Fig. 2A shows that 10 nM R1881 treatment causes
ruffles and protrusions (upper panels) within 20 min, together with
a simultaneous and significant increase in P-Tyr spots, associated
with the ends of actin stress fibers at the cell periphery of NIH3T3
cells (lower panels). Since tyrosine phosphorylation of FAK and
the focal contact-associated protein paxillin is involved in cell
adhesion and motility [18,19], we analyzed the effect of androgen
treatment on FAK and paxillin tyrosine phosphorylation. Data in
Regulation of Cell Migration by Androgens
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Tyr 397 phosphorylation in lysates from NIH3T3 cells immuno-
precipitated with anti-P-Tyr antibody (lower panel). This effect is
maximal at 5 min and declines at 30 min of hormonal stimulation.
Tyr 118-phosphorylated paxillin parallels tyrosine phosphoryla-
tion of FAK upon androgen stimulation of cells (lower panel in
Fig. 2B). The pull-down is specific since neither P-Tyr FAK nor P-
Tyr paxillin were detected in lysates immunoprecipitated with IgG
antibody, used as a control. Again, upper panels in B show that
similar amounts of total FAK and paxillin were loaded in
immunoprecipitation experiments. The effect we observed is
androgen-specific, since neither estradiol (Fig. S3, panel A) nor
progestin R5020 (Fig. S3, panel B) affect FAK or paxillin tyrosine
phosphorylation. Finally, using anti-FAK antibody in an immu-
noprecipitation experiment we observed that 10 nM R1881
stimulation of quiescent NIH3T3 cells markedly increases P-Tyr
397-FAK and P-Tyr 118-paxillin (Fig. 2C). The anti-androgen
Casodex abolishes androgen-induced tyrosine phosphorylation of
FAK and paxillin. In cells stimulated with 1 pM R1881, which
only slightly stimulates cell migration, a weak increase in both P-
Tyr 397-FAK and P-Tyr 118-paxillin was observed (Fig. 2C).
Specificity of immunoprecipitation is confirmed by the absence of
FAK or P-Tyr 397 FAK or P-Tyr 118 paxillin in lysates
immunoprecipitated with a control IgG antibody.
Since FAK activity is also regulated by phosphorylation at Tyr
925 [19], we analyzed by Western blot the effect of androgens on
this phosphorylation. Data in Fig. 3A shows that stimulation of
NIH3T3 fibroblasts with 10 nM R1881 does not trigger P-Tyr
925-FAK phosphorylation. In contrast, EGF treatment of cells
markedly increases such a phosphorylation. These findings
Figure 1. R1881 stimulates migration in NIH3T3 fibroblasts. Quiescent NIH3T3 cells were used. In A, upper panels: Western blot of lysate
proteins from NIH3T3 and prostate cancer-derived LNCaP cells with anti-AR (left) or anti-tubulin (right) antibodies. In A, lower panels: NIH3T3 cells
were wounded and then left unstimulated or stimulated for the indicated time with R1881 (at 10 nM or 1 pM). When indicated, Casodex (Cx) was
added at a 1000-fold excess. Contrast-phase images are representative of four different experiments, each performed in duplicate. In B, migration
assay on collagen-coated (left graph) or uncoated (right graph) Transwell filters was performed in the absence or presence of the indicated
compounds. Casodex (Cx) was added at a 1000-fold excess. Migrated cells were stained as described in Methods and data were expressed as relative
increase in number of migrated cells. In C and D, growing NIH3T3 cells were transfected with siRNA Alexa Fluor 488 along with either control siRNA
(nt) or AR siRNA. After transfection, the cells were made quiescent. In C, the cells were allowed to migrate in collagen-coated Transwell filters in the
absence or presence of 10 nM R1881. Migrated cells were stained as described in Methods and data were expressed as relative increase in number of
migrated cells. In D, lysate proteins were immunoblotted using the antibodies against the indicated proteins (androgen receptor, AR; tubulin, tub). In
E, video time-lapse microscopy was followed in the absence or presence of 10 nM R1881. Data were analyzed as described in Methods and cell
motility expressed as average speed (microm/409; left graph). In both experimental conditions, no significant influence in linearity of cell motility was
detected (right graph). In B, C and E, means and SEM are shown; n represents the number of experiments. The statistical significance of results in B,
C and E was also evaluated by Student’s t test. In B (left and right panels), P values were ,0.005 for cells stimulated with 10 nM R1881. No
significance was attributed to the difference in relative migration between unstimulated cells and cells stimulated with 10 nM R1881 in the presence
of Casodex. Again, no significance was attributed to the difference in relative migration between unstimulated cells and cells stimulated with 1 pM
R1881. In C, the difference in relative migration between cells transfected with AR siRNA and those transfected with control siRNA and challenged
with 10 nM R1881 was significant (P,0.001). Also significant (P,0.001) was the difference in relative migration between cells transfected with control
siRNA and left unstimulated or stimulated with 10 nM R1881. In E, the difference in cell motility between unstimulated cells and cells stimulated with
10 nM R1881 was significant (P,0.005).
doi:10.1371/journal.pone.0017218.g001
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migration does not involve FAK phosphorylation at Tyr 925.
Androgen-induced cell migration: the role of FAK
To further analyze the role of FAK in androgen-induced cell
migration, we used FAK+/+ and FAK-/- fibroblasts. The Western
blot in Fig. 3B confirms that FAK-/- fibroblasts do not express
FAK (upper panel), while they still express AR (middle panel). The
lower panel shows that similar amounts of lysate proteins were
loaded. Stimulation of FAK+/+ fibroblasts with 10 nM R1881
induces strong tyrosine phosphorylation of FAK (upper panels in
C) and paxillin (lower panels in C), thus indicating that paxillin
tyrosine phosphorylation is controlled by FAK activity in
androgen-treated cells. In contrast, 10 nM R1881 fails to induce
both FAK and paxillin tyrosine phosphorylation in FAK-/-
fibroblasts (upper and lower panels in C).
Finally, both FAK+/+ as well as FAK-/- fibroblasts were
wounded and allowed to migrate in the absence or presence of
10 nM R1881. Contrast-phase images in Fig. 3D show that in
FAK+/+ fibroblasts, a significant number of cells move towards
the wound area upon challenging with 10 nM R1881. In contrast,
androgens do not stimulate migration of FAK-/- fibroblasts
(panel E).
Altogether, findings in Fig. 2 and 3 show that FAK contributes
to androgen-induced cell migration and that FAK activation
controls paxillin tyrosine phosphorylation in androgen-treated
cells.
Androgen-induced cell migration: the role of Rac 1
Ten nM R1881 triggers rapid Rac 1 activation in parallel with
cytoskeleton changes in NIH3T3 fibroblasts [10]. We therefore
addressed the upstream events regulating Rac 1 activation as well
as the role of Rac in androgen-induced cell motility of NIH3T3
fibroblasts.
Various mechanisms regulate the timing of activation of Rho
family proteins. Among these, FAK-dependent activation is
certainly involved [20]. We therefore analyzed by pull-down assay
the activation of Rac 1 in FAK+/+ and FAK-/- fibroblasts. Fig. 4A
shows that 10 nM R1881 stimulation activates Rac 1 in both
FAK+/+ and FAK-/- fibroblasts. These findings exclude the
possibility that androgen-dependent Rac activation depends on
FAK. Although similar amounts of Rac 1 were loaded, androgen-
induced Rac 1 activation is even more evident in FAK-/-
fibroblasts (Fig. 4A). This finding might be related to the dual role
of FAK, which acts as both a signaling kinase and as an adaptor/
scaffold protein. Thus, in FAK-/- fibroblasts the absence of FAK
Figure 2. R1881-stimulated fibroblast migration: the role of FAK and paxillin. In A, B and C, quiescent NIH3T3 cells were used. In A, cells
on coverslips were left unstimulated or stimulated for 20 min with 10 nM R1881 and then analyzed by IF for F-actin (upper images) and P-Tyr (lower
images). Images are representative of three independent experiments. Arrows indicate the protrusions and ruffles caused by androgen treatment of
cells. Scale bar, 5 microm. In B and C, cells were untreated or treated for the indicated times (B) or for 5 min (C) with R1881 (at 1 pM or 10 nM).
Casodex (Cx) was added at a 1000-fold excess. In B, cell lysates were immunoblotted using antibodies against FAK or paxillin (loading). Similar
amounts of lysate proteins were immunoprecipitated with control IgG (from Pierce; ctrl IgG) or anti-P-Tyr (anti-P-Tyr) antibody. Immunoprecipitated
proteins were analyzed using antibodies against the indicated proteins. For each phospho-blot, data were analyzed using the NIH Image J program
and expressed as relative increase. Numbers in the upper portion of corresponding blots represent the increase in P-FAK or P-paxillin. In C, cell lysates
containing similar amounts of total FAK (loading) were incubated with control IgG (ctrl IgG) or anti-FAK antibody and proteins in immunocomplexes
were blotted using antibodies against the indicated proteins.
doi:10.1371/journal.pone.0017218.g002
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the increase in androgen-induced Rac activation here observed.
In turn, it has been reported that Rac is an upstream regulator
of FAK in Schwann cell motility induced by IGF-1 [21]. We
therefore analyzed the role of Rac in androgen-induced FAK
activation. The Western blot analysis in Fig. 4B shows that
androgen significantly increases FAK auto-phosphorylation.
Addition of the Rac inhibitor HT1864 even enhances the
androgen effect, while EHT1846 alone does not significantly
modify the basal level of FAK p-Tyr phosphorylation. Altogether,
these findings support the view that FAK activation does not
depend on Rac and vice versa in NIH3T3 cells stimulated with
androgens.
Various signaling effectors, including Rho GTPase family
members, Akt and MAPKs, play a role in cell migration [20].
We therefore analyzed the effect of 10 nM R1881 on activation of
these effectors in NIH3T3 fibroblasts. Fig. S4 shows that no
change in Rho A activity was observed in pull-down assay of
androgen-treated NIH3T3 cell lysates (panel A). Again, 10 nM
R1881 had no effect on the activation of Akt (Fig. S4, panel B) or
extracellular-regulated kinase (Erk; Fig. S4, panel C). These
findings do not support the hypothesis that Rho, Akt or Erk
activation is involved in androgen-regulated cell migration in these
cells.
We therefore analyzed the role of Rac activation in regulation of
actin cytoskeleton and migration induced by androgens in
NIH3T3 cells. Fig. 4C shows that the Rac inhibitor EHT1846
greatly reduces cytoskeleton changes caused by 10 nM R1881
treatment of NIH3T3 cells. Consistently, EHT1864 inhibits
androgen-induced cell migration in both Transwell (Fig. 4D)
and wound scratch (Fig. 4E) assays.
Findings in Fig. 4 show that androgen-induced cell migration
involves Rac. The results also indicate that FAK and Rac are
independently activated and that both converge on cell migration
once activated.
Androgens induce cell migration in human fibrosarcoma
cells: the role of Rac 1
We investigate the effect of androgen in cell migration of human
fibrosarcoma HT1080 cells. The upper panel in Fig. 5A shows
that HT1080 cells express a low level of AR compared to that
expressed in LNCaP cells. It should be noted that expression of
AR is also much lower in NIH3T3 cells than in LNCaP cells
(Fig. 1) and [4]. AR expression was also detected by immunoblot
of HT1080 cell lysates with an antibody directed at COOH-
terminal sequence of AR (Fig. 5A, lower panel).
We then assessed by gene reporter assay the transcriptional
activity of AR in HT1080 cells. Fig. 5B shows that HT1080 cells
harbor a transcriptionally incompetent AR, as assayed using two
different ARE-reporter genes. This failure to induce gene
transcription is not due to the cellular milieu, since over-expression
of wt human AR (hAR) enables these cells to efficiently activate
Figure 3. R1881-stimulated fibroblast migration: the role of FAK. In A, quiescent NIH3T3 cells were used. Cells were untreated or treated for
5 min with R1881 (at 10 nM) or EGF (at 100 ng/ml; from Roche). Cell lysates were immunoblotted using antibodies against FAK or P-Tyr 925 FAK. In B,
C, D and E, quiescent FAK+/+ or FAK-/- fibroblasts were used. In B, cell lysates were analyzed by Western blot using antibodies against FAK, AR or
tubulin. In C, cells were untreated or treated for 5 min with 10 nM R1881 and lysates were immunoblotted with antibodies against the indicated
proteins. For each phospho-blot, data were analyzed using the NIH Image J program and expressed as relative increase. Numbers in the upper
portion of corresponding blots represent the increase in P-Tyr 397 FAK or P-Tyr 118 paxillin. In D and E, the cells were wounded and left unstimulated
or stimulated with 10 nM R1881. The cells were then allowed to migrate for 24 h. Contrast-phase images are representative of three different
experiments, each performed in duplicate.
doi:10.1371/journal.pone.0017218.g003
Regulation of Cell Migration by Androgens
PLoS ONE | www.plosone.org 5 February 2011 | Volume 6 | Issue 2 | e17218transcription upon androgen stimulation. The inset in panel B
confirms that wt hAR is actually over-expressed in HT1080 cells.
We then surveyed by IF analysis the effect of androgens on AR
nuclear translocation. Panel C shows that under basal conditions,
AR is equally distributed between nucleus and cytoplasm of
quiescent HT1080 cells. One-hour stimulation of cells with 10 nM
R1881 failed to induce AR nuclear translocation and a similarly
diffuse distribution of AR was observed at later time points (2 and
4 h; not shown). In contrast, images captured from prostate
cancer-derived LNCaP cells or Cos cells ectopically expressing wt
hAR show that 10 nM R1881 clearly induces nuclear transloca-
tion of AR (Fig. S5).
Finally, quiescent HT1080 cells were wounded and allowed to
migrate in the absence or presence of 10 nM R1881. Images in
Fig. 5D (upper panels) show that wound area is markedly reduced
in cells treated with 10 nM R1881. Control images captured at 0-
time or from untreated cells are shown for comparison. The anti-
androgen Casodex and the Rac inhibitor EHT1864 consistently
inhibit androgen-induced migration (Fig. 5D, lower panels). These
results show that through its receptor androgens also induce the
migratory phenotype in fibrosarcoma cells, further supporting the
role of Rac in this phenotype.
Androgen-triggered AR association with FlnA and
integrin beta 1 leads to FAK activation
In the search for a link between AR, focal contact sites and
cytoskeleton proteins, we reasoned that FlnA, an actin-binding
protein, might be involved. This hypothesis was based on the well-
known role of FlnA in cell motility [22] as well as the reported
interaction between AR and FlnA proteolytic peptides in various
cell types, including LNCaP cells [9,10].
Confocal microscopy analysis in Fig. 6A shows that challenging
quiescent NIH3T3 cells with 10 nM R1881 increases the co-
localizationbetweenAR/FlnAatcytoskeletonwithin5 min.Control
images (ctrl) were captured from cells stained with the FITC-
conjugated secondary antibody alone, as a control. They show that
Figure 4. R1881-stimulated fibroblast migration: the role of Rac. In A, quiescent FAK+/+ or FAK-/- fibroblasts were used. Cells were then left
unstimulated or stimulated for 5 min with 10 nM R1881 and lysate proteins were analyzed by immunoblot using anti-FAK (FAK), Rac (input) or
tubulin antibody. Rac activity in cell lysates was assayed in pull-down experiments (Rac-GTP). Data were analyzed using the NIH Image J program. In
androgen-treated FAK-null fibroblasts, the relative increase in Rac-GTP was 3.7-fold compared to the androgen-treated FAK+/+ fibroblasts. In B, C, D
and E, quiescent NIH3T3 cells were used. In B, cells were left unstimulated or stimulated for 5 min with 10 nM R1881 in the absence or presence of
EHT (20 microM). Control cells were treated with EHT alone. Lysates were analyzed by immunoblot using anti-P-Tyr 397 FAK (P-Tyr-FAK) or FAK (FAK)
antibodies. Data were analyzed using the NIH Image J program and expressed as relative increase. Numbers in the upper portion of corresponding
blots represent the increase in P-FAK. In C, cells on coverslips were left untreated or treated for 40 min with the indicated compounds. R1881 was
used at 10 nM and EHT 1864 at 20 mM. Cells were then analyzed by IF for F-actin. Images are representative of three independent experiments. Scale
bar, 5 microm. In D, migration assay on collagen-coated Transwell filters was performed in the absence or presence of the indicated compounds.
R1881 was used at 10 nM and EHT 1864 at 20 microM. Migrating cells were stained with Hoechst and counted with fluorescent microscope as
described in Methods. Data were expressed as relative increase in number of migrated cells. Means and SEM are shown; n represents the number of
experiments. The statistical significance of results was also evaluated by Student’s t test. P values were ,0.001 for cells stimulated with 10 nM R1881.
The difference in relative migration between cells challenged with 10 nM R1881 in the absence or presence of EHT was significant (P,0.001). The
difference in relative migration between unstimulated cells and cells stimulated with 10 nM R1881 in the presence of EHT or between unstimulated
cells and EHT-treated cells was not significant. In E, the cells were wounded and then left unstimulated or stimulated for the indicated time with
10 nM R1881 in the absence or presence of 20 microM EHT. Control cells were treated with EHT alone (at 20 microM). Contrast-phase images are
representative of three different experiments, each performed in duplicate.
doi:10.1371/journal.pone.0017218.g004
Regulation of Cell Migration by Androgens
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obtained from three independent experiments is presented in Fig. 6B.
FlnA directly interacts with the cytoplasmic domain of integrin
beta 1 and mediates actin-dependent processes [23]. We therefore
verified by immunoprecipitation experiments whether androgens
trigger a complex assembly made up of FlnA, AR and integrin
beta 1 in NIH3T3 cells. The immunoprecipitation experiment in
Fig. 6C shows that stimulation of NIH3T3 cells with 10 nM
R1881 induces recruitment of AR and integrin beta 1 to FlnA.
Again, stimulation with 1 pM R1881 increases association of
integrin beta 1 with FlnA, but fails to stimulate recruitment of AR
to this complex at levels comparable to those observed at 10 nM
R1881. Notably, Casodex prevents the 10 nM R1881-induced
association of AR with FlnA and integrin beta 1. Neither FlnA, nor
AR, nor integrin beta 1 were detected in lysates immunoprecip-
itated with anti-IgG antibody, used as a control.
Figure 5. Human fibrosarcoma HT1080 cells harbor transcriptionally inactive AR that stimulates cell migration through androgen
activation of Rac. Quiescent fibrosarcoma HT1080 cells were used. Panel A shows the Western blot of cell lysates with the N-20 (upper) or C-19
(lower) anti-AR antibody. Immunoblot analysis of lysates from growing LNCaP or NIH3T3 or 3T3-L1 cells was performed for comparison. In each panel,
the levels of tubulin (tub) were determined by Western blot. In B, the cells were transfected with either 3416 or 3424 ARE-luc constructs in the
absence or presence of human AR (hAR) expressing plasmid. Cells were made quiescent and then left unstimulated or stimulated for 18 h with 10 nM
R1881. Luciferase activity was assayed, normalized using beta-gal as an internal control, and expressed as fold induction. Data from three
independent experiments were analyzed. Means and SEM are shown; n represents the number of experiments. The statistical significance of results
was also evaluated by Student’s t test. In cells co-transfected with hAR and 3416 ARE-luc, the difference in ARE-luc induction between cells
challenged with 10 nM R1881 and unstimulated cells was significant (P,0.001). Also significant (P,0.001) was the difference in ARE-luc induction
between cells co-transfected with hAR and 3424 ARE-luc and left unstimulated or challenged with 10 nM R1881. Over-expression of hAR in HT1080
cells was verified by Western blot analysis using the C-19 anti-AR antibody (upper inset in B). The levels of tubulin (tub) were also determined (lower
inset in B). In C, cells on coverslips were left untreated or treated for 60 min with 10 nM R1881 and then analyzed by IF for AR (left) or nuclei
(Hoechst; right). Images are representative of three independent experiments. Scale bar, 5 microM. In D, the cells were wounded, then left
unstimulated or stimulated for the indicated time with 10 nM R1881. Casodex (Cx) was used at 1000-fold excess and EHT 1864 at 20 microM.
Contrast-phase images are representative of three different experiments.
doi:10.1371/journal.pone.0017218.g005
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that stimulation of NIH3T3 cells with 10 nM R1881 induces
recruitment of integrin beta 1 and FlnA to AR specifically
immunoprecipitated from lysates of NIH3T3 cells (Fig. 6D). Again,
stimulation with 1 pM R1881 fails to stimulate recruitment of
integrin beta 1 and FlnA to AR. Likewise, the complex assembly
induced by 10 nM R1881 was blocked by Casodex. Neither AR,
nor FlnA, nor integrin beta 1 were detected in lysates immunopre-
cipitated with IgG antibody, used as a control (Fig. 6D). Because of
the role of integrin beta 3 in filamin signaling [24], we also explored
whether this integrin participates in androgen signaling. Ten nM
R1881 increases association of AR with FlnA, but fails to induce
recruitment of integrin beta 3 to this complex in NIH3T3 cells (Fig.
S6). Expectedly, Casodex prevents the 10 nM R1881-induced
association of AR with FlnA.Regardless of experimental conditions,
a small amount of integrin beta 3 was detected in a co-
immunoprecipitation experiment (Fig. S6).
Finally, the role of FlnA/AR/integrin beta 1 complex in
androgen-induced effects on focal complexes was addressed by
siRNA experiments. Fig. 7A shows that knockdown of integrin
beta 1 abolishes the 10 nM R1881-induced P-Tyr 397-FAK
phosphorylation as well as P-Tyr 118 phosphorylation of paxillin
in lysates immunoprecipitated with anti-FAK antibody. In
control cells, transfected with non-targeting RNA, a weak co-
immunoprecipitation of integrin beta 1 with FAK was observed
under basal conditions. This association was significantly
stimulated by androgens. In all experimental conditions, similar
amounts of total paxillin were detected (Fig. 7A). Lastly,
quantification of P- FAK and P-paxillin phosphorylation under
the different experimental settings was calculated and graphically
shown (Fig. 7B).
Silencing of FlnA abolishes the 10 nM R1881-induced P-Tyr
397-FAK phosphorylation as well as P-Tyr 118 phosphorylation of
paxillin in lysates immunoprecipitated with anti-FAK antibody
(Fig. 7C). In cells transfected with non-targeting RNA, FlnA does
not co-immunoprecipitate with FAK under basal conditions.
Androgen treatment of cells induces this association and stimulates
recruitment of FlnA to FAK (Fig. 7C). Here again, no change in
the total amount of paxillin was detected (Fig. 7C). Quantification
of P-FAK and P-paxillin phosphorylation under the different
experimental conditions was also calculated and graphically shown
(Fig. 7D).
Figure 6. R1881-induced AR/FlnA/integrin beta 1 complex in fibroblasts. Quiescent NIH3T3 cells were left untreated (basal) or treated for
5 min with 10 nM R1881 (R1881). In A, cells on coverslips were visualized by IF for AR and FlnA. Images captured by confocal microscope show the
staining of AR (green) and FlnA (red). Right panels show the merged images. The lowest images are representative of a control IF staining devoid of
the primary anti-AR antibody (ctrl). Left image shows FITC-secondary antibody alone, middle image shows Fln A (red). Right image shows the merge.
Scale bar, 5 microM. Graph in panel B represents the quantification and statistical analysis of different experiments. AR/FlnA co-localization ratio was
calculated as described in Methods. Means and SEM are shown; n represents the number of experiments. The statistical significance of results was
also evaluated by Student’s t test. The difference in AR/FlnA co-localization ratio between unstimulated (basal) and R1881-stimulated cells was
significant (P,0.005). Also significant (P,0.005) was the difference in AR/FlnA co-localization ratio between control cells (ctrl) and either
unstimulated (basal) or R1881-stimulated cells. In C and D, quiescent NIH3T3 cells were left untreated or treated for 5 min with the indicated
concentrations of R1881. The anti-androgen Casodex (Cx) was used at 10 microM. Cell lysates were immunoblotted with antibody against the
indicated proteins (loading). Lysate proteins containing similar amounts of FlnA (C)o rA R( D) were immunoprecipitated with anti-FlnA (C) or anti-AR
(D) antibody. Similar amounts of lysate proteins were also immunoprecipitated with control IgG (ctrl IgG). Proteins in immunocomplexes were
analyzed using antibodies against the indicated proteins.
doi:10.1371/journal.pone.0017218.g006
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immunoprecipitation of FlnA/AR/FAK in lysates from NIH3T3
cells challenged with 10 nM R1881. Addition of Casodex to the
cell medium prevented the 10 nM R1881-induced FlnA/AR/
FAK complex assembly. Neither FlnA, nor AR, nor FAK were
detected in lysates immunoprecipitated with anti-IgG antibody,
used as a control (Fig. 8A). Under the same experimental
conditions, we did not detect AR/FAK complex in lysates from
NIH3T3 fibroblasts immunoprecipitated with either anti-FAK
(Fig. 8B) or anti-AR (Fig. 8C) antibody. In addition, confocal
microscopy analysis did not show AR/FAK co-localization in
androgen-treated NIH3T3 cells (Fig. S7). Collectively, these data
make unlikely a direct association between AR and FAK. Rather,
they suggest that upon androgen challenging the AR/FlnA-
associated integrins signal to other integrin molecules that in turn
recruit FAK, triggering its auto-phosphorylation. Therefore, the
failure to detect AR/FAK association by co-immunoprecipitation
might be due to a high dissociation rate of these large protein
complexes. However, other possibilities cannot be ruled out.
Taken together, results in Figs. 6, 7 and 8 support each other in
indicating that androgens challenge an AR/FlnA/integrin beta 1
complex outside cell nucleus. This complex controls FAK auto-
phosphorylation, which s poised downstream of the AR/FlnA/
integrin beta 1 complex assembly.
AR/FlnA complex is required for androgen-induced cell
migration as well as Rac 1 activation
To dissect the role of the AR/FlnA/integrin beta 1 complex in
androgen action, we silenced FlnA or integrin beta 1 in NIH3T3
fibroblasts and analyzed the effect of each knockdown in
androgen-induced Rac 1 activation. Fig. 9A shows that silencing
of either FlnA or integrin beta 1 abolishes the androgen activation
of Rac 1 analyzed by pull-down assay. The role of FlnA in
androgen-induced cell migration was supported by experiments in
panel B showing that FlnA knockdown (insert in panel B) almost
completely abolishes the migratory phenotype of hormone-treated
NIH3T3 fibroblasts.
The role of AR/FlnA association was further analyzed by
ectopically expressing in Cos-7 cells an AR-deleted mutant, unable
to interact with FlnA [9]. Fig. 9C (lower panels) confirms that
regardless of hormonal stimulation this mutant does not undergo
association with FlnA. In contrast, the wild-type AR clearly co-
immunoprecipitates with FlnA upon 10 nM R1881 stimulation.
Upper panels in C show that similar amounts of AR or FlnA or
tubulin were loaded in the co-immunoprecipitation experiment.
Using the same experimental conditions, we observed that the
mutant AR fails to induce tyrosine phosphorylation of both FAK
and paxillin upon 10 nM R1881 stimulation (Fig. 9D). In cells
transfected with wt AR, R1881 triggers FAK activation and
Figure 7. R1881-induced AR/FlnA/integrin beta 1 complex controls FAK activation and tyrosine paxillin phosphorylation in
fibroblasts. Growing NIH3T3 cells were transfected with control siRNA (non-targeting) or integrin beta 1 siRNA (A) or FlnA siRNA (C) as described in
Methods. After transfection, cells were made quiescent and then untreated or treated for 5 min with 10 nM R1881. Upper sections show the Western
blot of corresponding cell lysates with anti-integrin beta 1 (A) or FlnA (C) antibodies. The levels of FAK and paxillin were also assessed by Western
blot. Lysate proteins were immunoprecipitated with anti-FAK antibody (lower sections in A and C) and proteins in immunocomplexes were analyzed
by Western blot using the antibodies against the indicated proteins. The increase in P-FAK and P-paxillin was analyzed using the NIH Image J
program and results are graphically expressed as relative increase. The graph in B refers to the experiment in A, whereas the graph in D refers to the
experiment in C.
doi:10.1371/journal.pone.0017218.g007
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of total FAK were loaded, an increase in P-Tyr FAK was observed
in lysates from untreated Cos cells ectopically expressing the
mutant AR when compared with untreated cell expressing wt AR.
These findings might be related to the scaffolding role of FlnA.
Thus, the failure of mutant AR to interact with FlnA could fully
channel FlnA towards integrin beta 1 or other proteins (eg Trio,
ezrin). As a consequence, the binding of integrin beta 1 to FAK or
the interaction of these proteins with the FAK-FERM domain
could be facilitated. In such a way, allosteric or conformational
restraints limiting FAK activity might be removed and FAK
activation enhanced [19].
Although unable to interact with FlnA, the mutant AR still
mediates androgen-induced DNA synthesis as shown by BrdU
incorporation analysis of AR-negative human mammary cancer-
derived MDA-MB231 cells ectopically expressing this mutant
(Fig. 9E). In the same experiment, we analyzed for comparison
BrdU incorporation induced by androgen stimulation of MDA-
MB231 cells ectopically expressing wt AR (Fig. 9E).
Collectively, our findings show that androgen-triggered AR/
FlnA/integrin beta 1 complex assembly controls FAK and Rac
activation as well as migration in NIH3T3 fibroblasts, whereas it
does not affect DNA synthesis.
Discussion
In different cell types androgens stimulate signaling pathway
activity usually triggered by growth factors, cytokines and extra
cellular matrix (ECM). This ‘non-genomic’ action occurs within
seconds or minutes and is independent of steroid receptor
transcriptional activity [25]. Signaling activation by androgens as
well as by other sex steroids controls cell growth in mouse models
of mammary and prostate tumorigenesis and cell cycle progres-
sion, epigenetic modifications, steroid receptor (SR) localization as
well as cytoskeleton changes in various cell types [4,26–39].
In this paper we report a novel non-genomic action of classical
AR. In NIH3T3 fibroblasts and human fibrosarcoma HT1080
cells, a physiological concentration of androgen promotes
migration. Stimulation of cell migration is also observed in
NIH3T3 fibroblasts triggered by DHT (not shown) and androgen
specificity is shown by the failure of estradiol or progestins to
trigger the migratory phenotype of NIH3T3 fibroblasts. In fact,
these cells harbor low levels of classical AR, but do not express
ERs or PR (present data) and [4].
We analyzed the molecular mechanism underlying androgen-
induced cell migration in mouse NIH3T3 fibroblasts. In these cells,
R1881rapidly triggers assemblyofa complexmade upofAR,FlnA
and integrin beta1 at a concentration stimulating migration
(10 nM), but not at a concentration that poorly drives migration
whereas actively induces G1-S transition (1 pM) [4]. siRNA
interference experiments show that the AR/FlnA/integrin beta 1
complex controls androgen-induced cell migration in NIH3T3
fibroblasts. In apparent contrast with our results, previous findings
have reported that stimulation of prostate cancer cells with
testosterone-BSA reduces their migration rate. This inhibitory
effect is, however, insensitive to three different anti-androgens and
has been attributed to a membrane AR (mAR) [37,40]. Our
previous [4] and present findings show that AR expressed in
fibroblasts is the classical AR since its DNA sequence contains the
predicted sequence of mouse AR [4], it is sensitive to the anti-
androgen Casodex and, more importantly it can be silenced by
targeting the AR mRNA with a consequent loss of the androgen-
induced migratory phenotype. Further, AR expressed in NIH3T3
fibroblasts does not seem to be localized at cell membrane, as shown
by confocal microscopy analysis. Thus, on the basis of different
criteria it appears to be distinct from AR identified on plasma
membranesofprostateLNCaPcells.Theoppositeactionofclassical
AR and mAR refractory to anti-androgens on cell migration might
Figure 8. R1881 induces AR/FlnA/integrin beta 1/FAK complex
in fibroblasts. Quiescent NIH3T3 cells were used. In A, cells were left
untreated or treated for 5 min with 10 nM R1881 (R1881) in the
absence or presence of 10 mM Casodex (Cx). Lysate proteins were
immunoprecipitated with either control (Ctrl IgG) or anti-integrin beta 1
antibody. In B, cells were left untreated or treated for 5 min with 10 nM
R1881 (R1881) in the absence or presence of 10 microM Casodex (Cx).
Lysate proteins were immunoprecipitated with either control (Ctrl IgG)
or anti-FAK antibody. In C, cells were left untreated or treated for 5 min
with R1881 (1 pM or 10 nM) in the absence or presence of 10 microM
Casodex (Cx). Lysate proteins containing similar amounts of FAK or
tubulin (loading) were immunoprecipitated with either control (Ctrl IgG)
or anti-AR antibody. In A, B and C, proteins in immunocomplexes were
analyzed by immunoblotting using antibodies against the indicated
proteins. When indicated, lysate proteins from LNCaP cells were
analyzed for AR expression by immunoblotting with anti-AR antibody.
doi:10.1371/journal.pone.0017218.g008
Regulation of Cell Migration by Androgens
PLoS ONE | www.plosone.org 10 February 2011 | Volume 6 | Issue 2 | e17218alsoimplicatea negativereciprocal crosstalkincellsexpressing both
receptors, such as LNCaP.
Our findings indicate that AR is a ‘hub protein’ that links
androgen signaling to FlnA and integrin beta 1 in NIH3T3
fibroblasts. Results obtained using FlnA and integrin beta 1
silencing support an unexpected model of ’inside-out’ integrin
activation by steroid hormones. Noteworthy, integrin beta 1 is
closely related to primordial germ cell (PGC) migration and mouse
Figure 9. Role of AR, FlnA and integrin beta 1 in androgen-triggered activation of signaling responsible for fibroblast migration. In
A, growing NIH3T3 cells were transfected with control siRNA (nt) or integrin beta 1 siRNA or FlnA siRNA as described in Methods. After transfection,
the cells were made quiescent and then left untreated or treated for 5 min with 10 nM R1881. The upper section shows the Western blot of
corresponding cell lysates with anti-integrin beta 1 (left) or FlnA (right) antibody. The levels of tubulin were also assessed by Western blot (tub). Cell
lysates containing similar amounts of total Rac (input) were used to assay Rac activation in pull-down experiments (Rac-GTP). Data were analyzed
using the NIH Image J program and expressed as relative increase. Numbers in the upper portion of corresponding blots represent the increase in
Rac-GTP. In B, growing NIH3T3 cells were transfected with siRNA Alexa Fluor 488 along with either control siRNA (nt) or FlnA siRNA. The cells were
made quiescent and then allowed to migrate in collagen-coated Transwell filters in the absence or presence of 10 nM R1881. Migrated cells were
scored by fluorescent microscope as described in Methods and data expressed as relative increase in number of migrated cells. Results from several
independent experiments were collected and analyzed. Means and SEM are shown. n represents the number of experiments. The statistical
significance of results was also evaluated by Student’s t test. In cells challenged with 10 nM R1881, the difference in relative migration between cells
transfected with FlnA siRNA and those transfected with control siRNA was significant (P,0.001). Also significant (P,0.005) was the difference in
relative migration between cells transfected with control siRNA and left unstimulated or stimulated with 10 nM R1881. The inset in B shows the
Western blot of lysate proteins with anti FlnA (upper) or anti tubulin (lower) antibodies. In C and D, AR-negative Cos-7 cells were transfected with wt
human AR (AR wt) or its mutant (AR mut) unable to interact with FlnA. After transfection, the cells were made quiescent and then left untreated or
treated for 5 min with 10 nM R1881. In C, lysate proteins containing similar amounts of AR or FlnA or tubulin (upper section) were
immunoprecipitated using anti-FlnA antibody. Proteins in immune complexes were analyzed by Western blotting using the antibodies against the
indicated proteins (lower section). In D, cell lysates were analyzed by immunoblotting using anti-P-Tyr 397 FAK (P-FAK), FAK (FAK), anti-P-Tyr 118
paxillin (P-Pax), or paxillin (pax) antibodies. Data were analyzed using the NIH Image J program and expressed as relative increase. Numbers in the
lower portion of corresponding blots represent the increase in P-FAK or P-pax. Expression of wt AR or its mutant (AR mut) was verified by
immunoblotting using the C-19 anti-AR antibody (upper section). In E, AR-negative MDA-MB231 cells on coverslips were transfected with the pSG5
empty plasmid or pSG5- wt AR (AR wt) or pSV1 mutant AR (AR mut). After transfection, the cells were made quiescent and then left unstimulated or
stimulated for 18 h with 10 nM R1881. After in vivo pulse with bromodeoxyuridine (BrdU), DNA synthesis was analyzed by IF and calculated by the
formula: percentage of BrdU-positive cells= (No. of transfected BrdU-positive cells/No. of transfected cells) X 100. For each plasmid, data were
derived from at least 500 transfected cells. Results of three independent experiments were averaged. Means and SEM are shown. n represents the
number of experiments. The statistical significance of results was also evaluated by Student’ t test. The difference in BrdU incorporation between cells
transfected with wt hAR (wt) and those transfected with pSG5 empty vector stimulated with R1881 was significant (P,0.001). Also significant
(P,0.001) was the difference in BrdU incorporation between cells transfected with mutant hAR (mut) and those transfected with pSG5 empty vector
stimulated with R1881. Lysate proteins were also immunoblotted using the C-19 anti-AR antibody (upper inset in E). The levels of tubulin (tub) were
also assessed as a loading control (lower inset in E).
doi:10.1371/journal.pone.0017218.g009
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[41]. This phenotype is reminiscent of male androgen receptor
knockout (ARKO) mice, which exhibits severe developmental
defects and spermatogenesis arrest [42]. Thus, integrin beta 1
functions might intersect androgen signaling during embryogen-
esis. The AR/FlnA interaction here observed is an important part
of this process. A calpain-generated FlnA fragment has been
previously identified as an AR co-regulator in cell nuclei [9,10].
Confocal microscopy analysis here presented reveals a novel
intracellular localization of AR/FlnA complex that impacts
androgen-induced cell motility. These findings indicate that the
intracellular localization of this complex dictates androgen
responses. Thus, the AR/FlnA complex controls motility when
poised close to the signaling effectors at cytoplasm (present report),
while it helps the transcriptional machinery in nuclei [9,10]. The
recent observation that high levels of cytoplasmic FlnA are a
hallmark of metastatic prostate cancer [12] supports the hypothesis
that AR/FlnA complex detected upon androgen stimulation in
cytoplasm of embryonic fibroblasts might be recapitulated during
cancer progression and invasiveness. The behavior of highly
metastatic human fibrosarcoma HT1080 cells, which still respond
to androgen with increased motility, favors this hypothesis.
We have shown that 10 nM R1881 induces FAK auto-
phosphorylation and tyrosine phosphorylation of paxillin at
tyrosine 118. In contrast, weak FAK activation is observed at
suboptimal R1881 concentration (1 pM), which poorly stimulates
cell migration. Knockdown experiments of FlnA and integrin beta
1 reveal that both FAK activation and tyrosine phosphorylation of
paxillin are controlled by the upstream AR/FlnA/integrin beta 1
complex induced by androgens. In addition, findings in FAK-null
fibroblasts show that androgen-induced cell motility requires FAK.
These results support the role of FAK in non-genomic signaling of
steroids leading to cell migration and invasiveness. Rapid
activation of FAK by sex steroids has been previously reported
in breast cancer T47D [30] as well as MCF-7 cells [32], and a
correlation between FAK activation and breast cancer metastasis
has been described [43].
The focal adhesion scaffold protein paxillin mediates interaction
between integrins and FAK, and undergoes tyrosine phosphory-
lation through a FAK- or Src-mediated mechanism [18]. Findings
in FAK-/- fibroblasts show that androgen-induced phosphoryla-
tion of paxillin at tyrosine 118 depends on FAK. Nevertheless, this
does not exclude the possibility that Src is involved in this process,
since paxillin can be phosphorylated in additional tyrosine residues
[18] and FAK-null fibroblasts usually exhibit reduced Src activity
[19]. Interactions of FAK, Src, p130CAS and paxillin promote
focal contact/focal adhesion turnover at the leading edge in
fibroblasts [44]. Recruitment and activation of Src, FAK and
p130CAS by ligand-coupled steroid receptors has been described
in different cell types [32,34,35,45–47] and has been correlated to
proliferative and survival effects of steroids in breast and prostate
cancer cells [26,35,47].
Rho family proteins control cytoskeleton dynamics and cell
motility [20]. Small GTPases and their downstream effectors have
been implicated in steroid action in vitro and in vivo
[4,5,14,15,29,30,37]. The present findings causally correlate
androgen activation of Rac 1 to the upstream AR/FlnA/integrin
beta 1 complex, further pointing to the key role of this complex in
hormonal action. As regards Rac activation, it should be noted
that FlnA directly interacts with Trio, a guanine exchange factor
(GEF) for Rac and Rho G [48]. FlnA also interacts with Rac and
Fil-GAP for Rac [22,49]. These interactions might contribute to
Rac regulation by androgens. Nonetheless, the finding that
integrin beta 1 silencing also abolishes Rac activation (Fig. 9A)
suggests that FlnA requires integrin beta 1 to activate Rac upon
androgen challenging of the cells. Our findings in FAK-null
fibroblasts or use of the Rac inhibitor EHT show that androgen-
induced FAK or Rac activation are independent of each other.
The absence or inhibition of either FAK or Rac, even induces a
stronger activation of the other. Such a forward loop could be
explained by the absence of FAK association with Rho-GTPases
regulators in FAK-null fibroblasts. This might enable the increase
in androgen-induced Rac activation observed in these cells.
Conversely, in cells treated with the Rac inhibitor EHT, the
Trio-GEF might be channeled towards the FERM domain of
FAK, thus removing conformational restraints limiting FAK
activity. The present findings indicate that activity of both FAK
and Rac is mutually and discretely regulated by the upstream AR/
FlnA/ntegrin beta 1 complex. This control ensures a balance
between FAK-regulated cell adhesion and Rac-induced cytoskel-
eton changes, so that cells can modulate their migration rate.
Results with HT1080 cells call for additional comments.
Epidemiological and clinical studies suggest that age, sex and
hormonal milieu exert an important influence on the natural
history of human mesenchymal tumors. SRs, including AR, have
been previously detected in a large set of human soft tissue
sarcomas of different histological origin [50]. Nevertheless,
HT1080 cells have been considered AR-negative [5,51]. Our
findings obtained using two different anti-AR antibodies as well as
the inhibition of cell motility by the anti-androgen Casodex reveal
that HT1080 cells harbor low levels of classical AR that mediate
androgen-induced migration but are unable to activate gene
transcription, as assessed by gene reporter assay. Consistent with
these latter findings, it has been previously reported that
androgens do not activate tissue plasminogen activator-CAT
reporter construct transiently transfected in HT1080 cells [51].
Thus, in HT1080 and NIH3T3 cells, as well as in other non-
reproductive cells, the very low amount of steroid receptors (eg
AR, PR and ER beta) is responsible for their failure to activate
gene transcription (present report) and [4,52]. However, this low
amount of SRs efficiently activates signaling pathways upon
steroid stimulation. By over-expressing SRs in NIH3T3 [4], Cos
[4], rat uterine stromal [52] and HT1080 cells, gene transcription
can be rescued in the presence of a rapid, transient and vigorous
stimulation of signaling pathways. In contrast, low amounts of AR
are sufficient to activate signaling transducing effectors [4]. Thus,
differential responses may be achieved in different cells depending
on their SR content. In cells (eg breast and prostate-derived cancer
cells) expressing nano-molar amounts of SRs, these undergo
significant dimerization in the presence of ligand and respond to
nano-molar concentrations of steroid hormones with optimal
nuclear translocation and transcriptional activation. In contrast, in
cells expressing sub-nano-molar concentrations of SRs, the
majority of receptor molecules are in the monomeric form in
the absence of ligand. In this form, SRs are prevalently localized in
the cytoplasm, where they activate signaling cascades.
Androgen-induced cytoskeleton changes have been previously
observed in HT1080 cells engineered to stably over-express AR
(HT-AR1 cells) and these changes have been correlated to the
transcriptional up-regulation of Rho B mediated by AR [5]. It is
unlikely that this transcriptional control occurs in our experimen-
tal setting, since AR expressed in HT1080 cells is devoid of
transcriptional activity. Furthermore, androgens fail to activate
Rho in NIH3T3 fibroblasts (Fig. S4, A). In HT1080, as in
NIH3T3 cells, Rac inhibition impairs androgen-induced cell
motility, suggesting that the same signaling effectors are engaged
by androgens in both mesenchymal and mesenchimal transformed
cells. Thus, HT1080 cells represent a new model of hormone-
Regulation of Cell Migration by Androgens
PLoS ONE | www.plosone.org 12 February 2011 | Volume 6 | Issue 2 | e17218responsive cells that will prove useful in dissecting the role of
androgen signaling in human cancer metastasis.
In summary, this report reveals new facets of androgen biology.
It shows for the first time that classical AR stimulates cell
migration and analyzes the molecular mechanism underlying this
action. Our findings identify the androgen-induced AR/FlnA/
integrin beta 1 complex as being the initial event triggering cell
motility. By further exploiting this complex in a wide range of
human androgen-dependent cancers, it should be possible to gain
valuable insights into the role of androgens in human cancer
metastasis. Lastly, steroid receptor sequences interacting with
signaling effectors or scaffolds represent potential therapeutic
targets to specifically inhibit signaling effectors involved in
hormone action. This is, indeed, the case of ER alpha and AR
sequence interacting with Src [36,38].
Materials and Methods
Constructs
cDNA encoding the wild-type hAR was in pSG5 [53]. The
mutant AR (D622-670 hAR) was in psV1 expression vector [9].
The 3416 construct, containing four copies of the wild-type slp-
HRE2 (59-TGGTCAgccAGTTCT-39) and the 3424 construct (59-
TGGACAgccAGTTCT-39) were cloned in the NheI site in pTK-
TATA-Luc [54].
Cell culture, siRNA, transfection and transactivation
assays
FAK-/- and FAK+/+ fibroblasts (ATCC) were cultured
according to the manufacturer’s instructions and made quiescent
as reported [4]. FAK-null fibroblasts were made quiescent by 12 h
of serum starvation. Human fibrosarcoma HT1080 and mouse
3T3-L1 cells were cultured in Dulbecco’s modified Eagle medium
(DMEM)supplementedwith10%fetal calf serum (FCS), 100 U/ml
penicillin and 100 microg/ml streptomycin, and maintained at
37uC in humidified 5% CO2 atmosphere. The cells were made
quiescent by serum starvation (0.5% charcoal-stripped FCS) for
18 h. Mouse embryo NIH3T3 fibroblasts, Cos-7, LNCaP and
MDA-MB231 cells were cultured and made quiescent as described
[4,26,35]. Cos-7 and MDA-MB231 cells were transfected with 1
microg of each purified plasmid, using the Superfect reagent
(Qiagen, GMbH). After 24 h, transfected cells were made quiescent
and used. For integrin beta 1 siRNA, a pool of 4 target-specific 20–
25 nt siRNAs (Santa Cruz) was used. FlnA silencing was performed
using a pool of 3 target-specific 20–25 nt siRNAs (Santa Cruz). For
AR siRNA, a pool of 4 target-specific 20–25 nt si RNAs (Santa
Cruz) was used. Non-targeting siRNAs, containing a scrambled
sequence, was from Santa Cruz. siRNA was transfected using
Lipofectamine
TM 2000 (Gibco). After transfection, the cells were
made quiescent for 48 h and then used. Transactivation assay in
subconfluent HT1080 cells was performed in phenol red–free
DMEM containing 10% charcoal-stripped serum. Cells were
transfected by Superfect with 2 microg of 3416-pTK-TATA- Luc
or 3424-pTK-TATA-Luc construct, alone or with 1 mg pSG5-
hAR-expressing plasmid. After 24 h, transfected cells were left
unstimulated or stimulated with 10 nM R1881 (Perkin Elmer) for
18 h. Luciferase activity from lysates was measured using a
luciferase assay system (Promega) and values corrected using
CH110-expressed-beta-galactosidase activity (GE Healthcare).
Wound scratch analysis, Transwell assay and time-lapse
video microscopy
For wound scratch assay, quiescent cell monolayers at
confluence were wounded using sterile pipette tips, and then
washed in PBS. To avoid proliferation, the cells were treated with
cytosine arabinoside (at 100 microM; Sigma) and then left
unstimulated or stimulated for different times with the indicated
concentrations of R1881. Casodex was from Astra Zeneca.
Estradiol was from Sigma and the progestin R5020 from
Roussel-Uclaf. The Rac 1 inhibitor EHT 1864 (Sigma) [55] was
added 4 h before hormonal stimulation. Fields were analyzed with
DMIRB inverted microscope (Leica) using N-Plan 10x objective
(Leica). Contrast-phase images were captured using a DC200
camera (Leica) and acquired using IMI1000 (Leica) software.
Transwell assay was performed using uncoated or collagen- (Type
I from rat-tail at 100 mg/ml; BD Biosciences) coated Transwell
chamber system with 8 microm pore polycarbonate membrane
(Nunc). NIH3T3 cells were plated in the upper chamber at 2610
4
per well in 200 microl of phenol red-free DMEM containing 0.5%
BSA. For AR and FlnA siRNA studies, NIH3T3 cells were co-
transfected with siRNA Alexa Fluor 488 to help identify
transfected cells. Cells were allowed to migrate for 6 h in a
humidified chamber at 37uC with 5% CO2 in the absence or
presence of the indicated compounds. Cells on the upper side were
then detached. In NIH3T3 fibroblasts, cells on the underside were
fixed in 4% paraformaldehyde for 15 min and stained with
Hoechst 33258 for 10 min. In siRNA Alexa Fluor 488-transfected
fibroblasts, the cells were fixed in 4% paraformaldehyde for
15 min. The cells were finally counted with a DMBL (Leica)
fluorescent microscope using HCPL Fluotar 20x objective in ten
random microscopic fields. The 2D random migration assay was
carried out by seeding growing NIH3T3 fibroblasts onto 12 well
plates at 2.5610
4 cells/well. Cells were made quiescent, and then
left unstimulated or stimulated with R1881. Cytosine arabinoside
(at 50 microM) was added to each sample. Cells were followed for
24 h and images from different samples were acquired every
10 min using the Zeiss Cell Observer System, made up of a
motorized inverted microscope (Axiovert 200M), an incubator
chamber for observation of living cells and a digital camera
(Axiocam H/R). The obtained movies were analyzed as described
[56], using the MotoCell semi-automatic tool. Quantitative
analysis of migration was performed using the statistical analysis
tool available within MotoCell. Average speed was calculated by
averaging the length of cell displacements at each 40 min time
step. For each cell, linearity was calculated as the ratio between net
displacement and total path length.
Cytoskeleton changes and DNA synthesis analysis
Cytoskeleton analysis in quiescent NIH3T3 cells was performed
as reported [4], using Texas red-labeled phalloidin (Sigma). EHT
1864 was added 2 h before hormonal stimulation. BrdU incorpo-
ration in transfected MDA-MB231 cells was analyzed by immuno-
fluorescence [26], using diluted (1:50 in PBS) mouse monoclonal
anti-BrdU antibody (clone BU-1, from GE Healthcare). Mouse
antibody was detected using diluted (1:200 in PBS) Texas red-
conjugated goat anti-mouse antibody (Jackson Laboratories).
Immunofluorescence and confocal microscopy
Cells on coverslips were fixed and permeabilized as described
[26].EndogenousARinLNCaPcellsandwild-type hARectopically
expressed in Cos cells were visualized as described, using the rabbit
polyclonal anti-C19 antibody [4]. In NIH3T3 and HT1080 cells,
AR was visualized using diluted (1:100 in PBS) rabbit polyclonal
anti-AR antibody (Ab-2, Neo-Markers). Rabbit antibody was
detected using diluted (1:200 in PBS containing 0.2% bovine serum
albumin) anti-rabbit fluorescein-conjugated antibodies (Jackson
Laboratories). FlnA was detected using diluted (1:40 in PBS) goat
polyclonal anti-FlnA antibody (Ab11074; Abcam). Goat antibody
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conjugated antibody (Abcam). Total P-Tyr was detected using
diluted(1:100inPBS)mousemonoclonal anti-P-Tyr antibody(clone
4G10, Upstate Biotechnology). Diluted (1:200 in PBS) anti-mouse
fluorescein isothiocyanate-conjugated antibody (Calbiochem) was
added to detect the primary mouse antibodies. Coverslips were
finally stained with Hoechst 33258, inverted and mounted in
Mowiol (Calbiochem). Fields were analyzed with a DMBL Leica
(Leica)fluorescentmicroscopeusingHCXPLApo63xoilandHCX
PL Fluotar 100x oil objectives. Images were captured using DC480
camera (Leica) and acquired using FW4000 (Leica) software.
Confocal microscopy analysis was performed using a Zeiss LSM
510 laser scanning confocal microscope as reported [33]. For AR/
FlnA co-localization analysis, we used Argon/2 (458, 477, 488, 514
nanometers) and HeNe1 (543 nanometers) excitation lasers, which
were separately switched on to reduce cross talk between the two
fluorochromes. The greenand the red emissionswereseparated bya
dichroicsplitter(FT560)andfiltered(515-to540-nmband-passfilter
for green and .610-nm long pass filter for red emissions. A
threshold was applied to the images to exclude about 99% of the
signal found in control images. The weighted co-localization
coefficient represents the sum of intensity of co-localizing pixels in
channels 1 and 2 as compared to the overall sum of pixel intensities
above threshold. This value could be 0 (no co-localization) or 1 (all
pixels co-localize). Bright pixels contribute more than faint pixels.
The co-localization coefficient represents the weighted co-localiza-
tion coefficients of Ch1 (red) with respect to Ch2 (green) for each
experiment [57]. The image collection periods and exposures were
identical for the different experimental conditions.
Lysates, immunoprecipitation, GTP-binding protein assay
and immunoblotting
Lysates (at 2 mg/ml protein concentration) were prepared as
described [34]. FlnA was immunoprecipitated using rabbit
polyclonal anti-FlnA antibody (Cell Signaling). FAK was immu-
noprecipitated using mouse monoclonal anti-FAK antibody (clone
77; BD Biosciences). Mouse monoclonal anti-P-Tyr antibody
(clone 4G10; Upstate Biotechnology) was used to immunoprecip-
itate P-Tyr phosphorylated proteins. Rac and Rho pull down
assays were performed as described [4], using the Rac or the Rho
activation kit (Upstate Biotechnology). AR was revealed using the
rabbit polyclonal anti-AR antibody (Ab-2; NeoMarkers) or the
rabbit polyclonal anti-AR antibodies (N-20 or C-19; Santa Cruz).
The rabbit polyclonal anti-ERalpha antibody (543; Santa Cruz)
was used to detect ERalpha. PR was detected using the mouse
monoclonal anti-PR antibody (6A1; Cell Signaling). The rabbit
polyclonal anti-FlnA antibody (Cell Signaling) was used to detect
FlnA. Integrin beta 1 was detected using rabbit polyclonal anti-
integrin beta 1 antibody (Chemicon International), whereas the
rabbit polyclonal anti-integrin beta 3 (Santa Cruz) was used to
detect integrin beta 3. Total FAK, P-Tyr 397, P-Tyr 925 FAK,
total Akt and P-Ser 473 Akt were detected using appropriate
antibodies (Cell Signaling). P-Tyr 118 paxillin was detected using
rabbit polyclonal anti-P-Tyr 118 paxillin antibody (BD Bioscienc-
es). Mouse monoclonal anti-paxillin antibody (clone 349; BD
Biosciences) was used to detect total paxillin. Rho A, Erk and P-
Tyr 204 Erk were detected using appropriate antibodies (Santa
Cruz). Immune-reactive proteins were revealed by the ECL
detection system (from GE Healthcare).
Supporting Information
Figure S1 Estradiol and progestins do not affect
fibroblast migration. NIH3T3 fibroblasts do not express
ERalpha or PR, as assessed by Western blot analysis of cell lysates
using appropriate antibodies (Fig. S1, A). Western blot analysis of
lysate proteins from breast cancer-derived cells (MCF-7 and T47D
cells) is shown for comparison. Western blot analysis using the
anti-tubulin antibody was performed as a loading control (tub). In
agreement with findings in A, contrast-phase images in B show
that quiescent NIH3T3 fibroblasts do not migrate in wound
scratch assay upon stimulation with 10 nM of E2 or R5020. In
contrast, the cells migrate upon 10 nM R1881 stimulation. The
effect of suboptimal (1 pM) R1881 concentration on cell migration
is negligible. Images are representative of two independent
experiments, each performed in duplicate.
(TIF)
Figure S2 Time course of androgen-induced cytoskele-
ton changes in NIH3T3 fibroblasts. Quiescent NIH3T3
fibroblasts on coverslips were left unstimulated or stimulated for
the indicated times with 10 nM R1881 and then analyzed by IF
for F-actin. Images are representative of three independent
experiments. Arrows mark the cytoskeleton changes (ruffles and
protrusions) induced by androgen treatment of NIH3T3 cells.
Scale bar, 5 microM.
(TIF)
Figure S3 Estradiol and progestins do not affect FAK
activation and paxillin tyrosine phosphorylation in
NIH3T3 cells. Quiescent NIH3T3 fibroblasts were left untreat-
ed or challenged for the indicated time with either 10 nM estradiol
(E2; panel A) or 10 nM R5020 (panel B). Similar amounts of total
FAK or paxillin (upper sections in A and B) were immunopre-
cipitated with anti-P-Tyr antibody. Proteins in immunocomplexes
were immunoblotted with antibodies against P-FAK or P-paxillin
(lower sections in A and B).
(TIF)
Figure S4 Ten nM R1881 does not activate Rho or Akt or
Erk in NIH3T3 fibroblasts. Quiescent NIH3T3 cells were
used. In A, cells were left untreated or treated for the indicated
times with 10 nM R1881 or EGF (100 ng/ml). Lysate proteins
were assayed for Rho activation in pull-down assay. Loaded
(input) and eluted (Rho-GTP) proteins were analyzed by
immunoblotting using the anti-Rho A antibody. In B and C, cells
were left untreated or treated for 5 minutes with the indicated
compounds (EGF was used at 100 ng/ml; R1881 was used at 1
pM or 10 nM). In B, lysate proteins were analyzed by
immunoblotting using anti P-AKT (upper panel) or anti-AKT
(lower panel) antibodies. In C, lysate proteins were analyzed by
immunoblotting using anti-P-Erk (upper panel) or anti-Erk (lower
panel) antibodies.
(TIF)
Figure S5 Androgen induces nuclear translocation of AR
in human prostate cancer-derived LNCaP cells and Cos
cells ectopically expressing wild-type hAR. Left panels:
LNCaP cells on coverslips were used and made quiescent. Right
panels: AR-negative Cos cells on coverslips were transiently
transfected with wild-type hAR-encoding plasmid, then made
quiescent. The cells were left unstimulated or stimulated for 1 h
with 10 nM R1881 and then analyzed by IF for AR as described
in Methods. AR intracellular distribution was analyzed by
confocal microscopy (LNCaP cells) or immunofluorescence
microscopy (Cos cells). For each cell line, several fields were
analyzed and representative images from two independent
experiments were captured and shown. Scale bars, 10 microM
(LNCaP cells) or 5 microM (Cos cells).
(TIF)
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of integrin beta 3 to AR/FlnA complex in NIH3T3
fibroblasts. Quiescent NIH3T3 cells were left untreated (basal)
or treated for 5 min with 10 nM R1881 (R1881) in the absence or
presence of 10 mM Casodex (Cx). Cell lysates were immunoblotted
with antibody against FlnA (loading). Lysate proteins containing
similar amounts of FlnA were immunoprecipitated with either
control (ctrl) or anti-FlnA antibody. Proteins in immunocomplexes
were analyzed by immunoblotting using antibodies against the
indicated proteins.
(TIF)
Figure S7 Ten nM R1881 does not induce AR/FAK co-
localization in NIH3T3 fibroblasts. Quiescent NIH3T3 cells
on coverslips were treated for 5 min with 10 nM R1881. Cells on
coverslips were visualized by IF for AR and FAK as described in
Methods. Images captured by confocal microscope show the
staining of AR (green) and FAK (red). Lower panel shows the
merged image. Scale bar: 5 microM
(TIF)
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